- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Secondary Hyperparathyroidism
Total 971 results
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; University of Tromso; Sussex Partnership... and other collaboratorsRecruitingAnxiety | Mild to Moderate DepressionNorway
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingModerate to Severe Acute PainChina
-
AbbVieTerminated
-
University of California, IrvineRecruiting
-
Logan College of ChiropracticCompletedAnxiety, Mild to ModerateUnited States
-
OPKO Health, Inc.RecruitingSecondary Hyperparathyroidism | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Vitamin d DeficiencyUnited States
-
Rainer OberbauerAmgenCompletedSecondary Hyperparathyroidism | Left Ventricular Hypertrophy | Chronic Kidney Disease Requiring Chronic DialysisAustria
-
Alimentiv Inc.TakedaNot yet recruitingCrohn Disease | Moderately to Severely Active Crohn's Disease | Disease Crohn
-
Annecto LLCHoly Redeemer HospitalTerminatedMild to Moderate DepressionUnited States
-
Novartis PharmaceuticalsCompletedMild to Moderate HypertensionGermany
-
Guangdong Hengrui Pharmaceutical Co., LtdNot yet recruitingModerate to Severe Atopic DermatitisChina
-
SanofiRegeneron PharmaceuticalsRecruitingModerate to Severe Atopic DermatitisCanada
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Atopic DermatitisChina
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Shanghai Hengrui Pharmaceutical Co., Ltd.CompletedModerate to Severe Atopic DermatitisChina
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasTerminatedModerate to Severe Atopic DermatitisUnited States
-
Hospices Civils de LyonCompletedModerate to Severe Traumatic Brain InjuryFrance
-
Technische Universität DresdenCompletedModerate to Severe Atopic DermatitisGermany
-
University Hospital, SaarlandCompletedHyperparathyroidism, Secondary | RENAL INSUFFICIENCY, CHRONICGermany
-
Alnylam PharmaceuticalsNot yet recruitingMild to Moderate Hypertension
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBreast Cancer | Long-term Effects Secondary to Cancer Therapy in Adults | Skin Reactions Secondary to Radiation TherapyUnited States
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
PfizerRecruitingHealthy Volunteers | Moderate Hepatic Impairment | Severe Hepatic ImpairmentUnited States
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
-
Winthrop University HospitalTerminatedSecondary Hyperparathyroidism | Kidney Failure | Hyperphosphatemia | HypercalcemiaUnited States
-
AmgenCompletedCardiovascular Disease | Hyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Coronary Artery Calcification | Vascular Calcification | Kidney Disease | Calcification | Nephrology
-
University of LuebeckCompletedMild to Moderate Depressive SymptomsGermany
-
medac GmbHRecruitingModerate to Severe Atopic DermatitisFrance, Poland, Italy, Czechia
-
Guangzhou JOYO Pharma Co., LtdChengdu JOYO pharma Co., Ltd.Not yet recruitingModerate-to-severe Atopic Dermatitis
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisSpain, Czechia, United States, Australia, Croatia, Bulgaria, Poland, Canada, Germany, Hungary
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Recruiting
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisChina
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationModerate to Severe Atopic DermatitisChina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Shanghai Vinnerna Biosciences Co., Ltd.Sponsor GmbHTerminatedModerate to Severe COVID-19China, Uzbekistan
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Royal Victoria InfirmaryBritish Skin FoundationCompletedModerate to Severe Atopic EczemaUnited Kingdom
-
Jiangsu vcare pharmaceutical technology co., LTDRecruitingModerate to Severe Atopic DermatitisChina
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting